{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:39:45Z","timestamp":1794947985261,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-32711-6","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:56:22Z","timestamp":1765781782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Circadian disruption aggravates non-alcoholic fatty liver disease by activating RIPK1-RIPK3-MLKL axis in mice"],"prefix":"10.1038","volume":"16","author":[{"given":"Xiaopeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"32711_CR1","doi-asserted-by":"publisher","first-page":"1386905","DOI":"10.3389\/fimmu.2024.1386905","volume":"15","author":"X Luo","year":"2024","unstructured":"Luo, X. et al. Unveiling the role of disulfidptosis-related genes in the pathogenesis of non-alcoholic fatty liver disease. Front. Immunol. 15, 1386905. https:\/\/doi.org\/10.3389\/fimmu.2024.1386905 (2024).","journal-title":"Front. Immunol."},{"issue":"3","key":"32711_CR2","doi-asserted-by":"publisher","first-page":"103910","DOI":"10.1016\/j.drudis.2024.103910","volume":"29","author":"S Wei","year":"2024","unstructured":"Wei, S. et al. NAFLD and NASH: etiology, targets and emerging therapies. Drug Discov Today. 29 (3), 103910. https:\/\/doi.org\/10.1016\/j.drudis.2024.103910 (2024).","journal-title":"Drug Discov Today"},{"issue":"4","key":"32711_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3892\/ijmm.2024.5412","volume":"54","author":"J Sun","year":"2024","unstructured":"Sun, J., Jin, X. & Li, Y. Current strategies for nonalcoholic fatty liver disease treatment (Review). Int. J. Mol. Med. 54 (4), 88. https:\/\/doi.org\/10.3892\/ijmm.2024.5412 (2024).","journal-title":"Int. J. Mol. Med."},{"issue":"14","key":"32711_CR4","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.3390\/nu16142220","volume":"16","author":"M Beygi","year":"2024","unstructured":"Beygi, M. et al. Management of Metabolic-Associated fatty liver Disease\/Metabolic Dysfunction-Associated steatotic liver disease: from medication therapy to nutritional interventions. Nutrients 16 (14), 2220. https:\/\/doi.org\/10.3390\/nu16142220 (2024).","journal-title":"Nutrients"},{"issue":"2","key":"32711_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/ueg2.12525","volume":"12","author":"J Zeng","year":"2024","unstructured":"Zeng, J., Fan, J. G. & Francque, S. M. Therapeutic management of metabolic dysfunction associated steatotic liver disease. United Eur. Gastroenterol. J. 12 (2), 177\u2013186. https:\/\/doi.org\/10.1002\/ueg2.12525 (2024).","journal-title":"United Eur. Gastroenterol. J."},{"issue":"2","key":"32711_CR6","doi-asserted-by":"publisher","first-page":"101174","DOI":"10.1016\/j.aohep.2023.101174","volume":"29","author":"S Li","year":"2024","unstructured":"Li, S. et al. Administration of Silymarin in NAFLD\/NASH: A systematic review and meta-analysis. Ann. Hepatol. 29 (2), 101174. https:\/\/doi.org\/10.1016\/j.aohep.2023.101174 (2024).","journal-title":"Ann. Hepatol."},{"key":"32711_CR7","doi-asserted-by":"publisher","unstructured":"Ran, Q. et al. Mechanism insights into the pleiotropic effects of nobiletin as a potential therapeutic agent on non-alcoholic fatty liver disease (NAFLD). Biomed. Pharmacother. 173, 116322. https:\/\/doi.org\/10.1016\/j.biopha.2024.116322 (2024).","DOI":"10.1016\/j.biopha.2024.116322"},{"issue":"1","key":"32711_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41398-020-0694-0","volume":"10","author":"WH Walker","year":"2020","unstructured":"Walker, W. H. 2 et al. Circadian rhythm disruption and mental health. Transl Psychiatry. 10 (1), 28. https:\/\/doi.org\/10.1038\/s41398-020-0694-0 (2020).","journal-title":"Transl Psychiatry"},{"issue":"4","key":"32711_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3390\/biom11040487","volume":"11","author":"A Montaruli","year":"2021","unstructured":"Montaruli, A. et al. Biological rhythm and chronotype: new perspectives in health. Biomolecules 11 (4), 487. https:\/\/doi.org\/10.3390\/biom11040487 (2021).","journal-title":"Biomolecules"},{"issue":"2","key":"32711_CR10","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3390\/ijms22020676","volume":"22","author":"AWC Man","year":"2021","unstructured":"Man, A. W. C., Li, H. & Xia, N. Circadian rhythm: potential therapeutic target for atherosclerosis and thrombosis. Int. J. Mol. Sci. 22 (2), 676. https:\/\/doi.org\/10.3390\/ijms22020676 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"32711_CR11","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1053\/j.gastro.2015.11.043","volume":"150","author":"H Reinke","year":"2016","unstructured":"Reinke, H. & Asher, G. Circadian clock control of liver metabolic functions. Gastroenterology 150 (3), 574\u2013580. https:\/\/doi.org\/10.1053\/j.gastro.2015.11.043 (2016).","journal-title":"Gastroenterology"},{"issue":"11","key":"32711_CR12","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41575-023-00792-1","volume":"20","author":"N Bolshette","year":"2023","unstructured":"Bolshette, N. et al. Circadian regulation of liver function: from molecular mechanisms to disease pathophysiology. Nat. Rev. Gastroenterol. Hepatol. 20 (11), 695\u2013707. https:\/\/doi.org\/10.1038\/s41575-023-00792-1 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"32711_CR13","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1038\/s41467-024-49852-3","volume":"15","author":"HA Duong","year":"2024","unstructured":"Duong, H. A. et al. Environmental circadian disruption re-writes liver circadian proteomes. Nat. Commun. 15 (1), 5537. https:\/\/doi.org\/10.1038\/s41467-024-49852-3 (2024).","journal-title":"Nat. Commun."},{"key":"32711_CR14","doi-asserted-by":"publisher","first-page":"154337","DOI":"10.1016\/j.metabol.2020.154337","volume":"111S","author":"A Mukherji","year":"2020","unstructured":"Mukherji, A., Dachraoui, M. & Baumert, T. F. Perturbation of the circadian clock and pathogenesis of NAFLD. Metabolism 111S, 154337. https:\/\/doi.org\/10.1016\/j.metabol.2020.154337 (2020).","journal-title":"Metabolism"},{"issue":"23","key":"32711_CR15","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.3390\/nu14235053","volume":"14","author":"N Perez-Diaz-Del-Campo","year":"2022","unstructured":"Perez-Diaz-Del-Campo, N. et al. Role of circadian clock on the pathogenesis and lifestyle management in Non-Alcoholic fatty liver disease. Nutrients 14 (23), 5053. https:\/\/doi.org\/10.3390\/nu14235053 (2022).","journal-title":"Nutrients"},{"issue":"3","key":"32711_CR16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.livres.2023.08.004","volume":"7","author":"JM Ferrell","year":"2023","unstructured":"Ferrell, J. M. Circadian rhythms and inflammatory diseases of the liver and gut. Liver Res. 7 (3), 196\u2013206. https:\/\/doi.org\/10.1016\/j.livres.2023.08.004 (2023).","journal-title":"Liver Res."},{"issue":"12","key":"32711_CR17","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.3390\/cells12121582","volume":"12","author":"E Jokl","year":"2023","unstructured":"Jokl, E. et al. Circadian disruption primes myofibroblasts for accelerated activation as a mechanism underpinning fibrotic progression in Non-Alcoholic fatty liver disease. Cells 12 (12), 1582. https:\/\/doi.org\/10.3390\/cells12121582 (2023).","journal-title":"Cells"},{"issue":"2","key":"32711_CR18","doi-asserted-by":"publisher","first-page":"e230472","DOI":"10.1530\/EC-23-0472","volume":"13","author":"R Maidstone","year":"2024","unstructured":"Maidstone, R. et al. Shift work and evening chronotype are associated with hepatic fat fraction and non-alcoholic fatty liver disease in 282,303 UK biobank participants. Endocr. Connect. 13 (2), e230472. https:\/\/doi.org\/10.1530\/EC-23-0472 (2024).","journal-title":"Endocr. Connect."},{"issue":"3","key":"32711_CR19","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1039\/d2an01546c","volume":"148","author":"YT Chen","year":"2023","unstructured":"Chen, Y. T. et al. Early detection of the initial stages of LED light-triggered non-alcoholic fatty liver disease by wax physisorption kinetics-Fourier transform infrared imaging. Analyst 148 (3), 643\u2013653. https:\/\/doi.org\/10.1039\/d2an01546c (2023).","journal-title":"Analyst"},{"key":"32711_CR20","doi-asserted-by":"publisher","first-page":"116723","DOI":"10.1016\/j.ejmech.2024.116723","volume":"277","author":"R Amorim","year":"2024","unstructured":"Amorim, R. et al. Decreasing the burden of non-alcoholic fatty liver disease: from therapeutic targets to drug discovery opportunities. Eur. J. Med. Chem. 277, 116723. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116723 (2024).","journal-title":"Eur. J. Med. Chem."},{"key":"32711_CR21","doi-asserted-by":"publisher","first-page":"1344376","DOI":"10.3389\/fendo.2024.1344376","volume":"15","author":"ME Chondrogianni","year":"2024","unstructured":"Chondrogianni, M. E. et al. Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe. Front. Endocrinol. (Lausanne). 15, 1344376. https:\/\/doi.org\/10.3389\/fendo.2024.1344376 (2024).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"32711_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/B978-0-323-90918-1.00007-1","volume":"206","author":"MA Quera-Salva","year":"2025","unstructured":"Quera-Salva, M. A., Hartley, S. & Uscamaita, K. Circadian rhythm disorders in the blind. Handb. Clin. Neurol. 206, 113\u2013123. https:\/\/doi.org\/10.1016\/B978-0-323-90918-1.00007-1 (2025).","journal-title":"Handb. Clin. Neurol."},{"issue":"5","key":"32711_CR23","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.3390\/ijms26052090","volume":"26","author":"A Andreadi","year":"2025","unstructured":"Andreadi, A. et al. Modified cortisol circadian rhythm: the hidden toll of Night-Shift work. Int. J. Mol. Sci. 26 (5), 2090. https:\/\/doi.org\/10.3390\/ijms26052090 (2025).","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"32711_CR24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41366-023-01435-w","volume":"48","author":"C Zhan","year":"2024","unstructured":"Zhan, C. et al. BMAL1 deletion protects against obesity and non-alcoholic fatty liver disease induced by a high-fat diet. Int. J. Obes. (Lond). 48 (4), 469\u2013476. https:\/\/doi.org\/10.1038\/s41366-023-01435-w (2024).","journal-title":"Int. J. Obes. (Lond)"},{"issue":"5","key":"32711_CR25","doi-asserted-by":"publisher","first-page":"C1158","DOI":"10.1152\/ajpcell.00551.2022","volume":"325","author":"LJ Daniels","year":"2023","unstructured":"Daniels, L. J. et al. Circadian regulation of liver metabolism: experimental approaches in human, rodent, and cellular models. Am. J. Physiol. Cell. Physiol. 325 (5), C1158\u2013C1177. https:\/\/doi.org\/10.1152\/ajpcell.00551.2022 (2023).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"32711_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.sleep.2024.02.044","volume":"117","author":"D Zhao","year":"2024","unstructured":"Zhao, D. et al. Effect of circadian rhythm change on gut microbiota and the development of nonalcoholic fatty liver disease in mice. Sleep. Med. 117, 131\u2013138. https:\/\/doi.org\/10.1016\/j.sleep.2024.02.044 (2024).","journal-title":"Sleep. Med."},{"issue":"2","key":"32711_CR27","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2741\/4892","volume":"26","author":"S Raza","year":"2021","unstructured":"Raza, S. et al. Current treatment paradigms and emerging therapies for NAFLD\/NASH. Front. Biosci. (Landmark Ed). 26 (2), 206\u2013237. https:\/\/doi.org\/10.2741\/4892 (2021).","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"32711_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10286020.2025.2482068","volume":"9","author":"YG Fu","year":"2025","unstructured":"Fu, Y. G. et al. Saikosaponin D, a triterpene saponin from bupleurum falcatum, restores circadian rhythm and attenuates hepatic fibrosis via Esr1-Per2 axis. J. Asian Nat. Prod. Res. 9, 1\u201318. https:\/\/doi.org\/10.1080\/10286020.2025.2482068 (2025).","journal-title":"J. Asian Nat. Prod. Res."},{"issue":"2","key":"32711_CR29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jhep.2023.10.025","volume":"80","author":"Z Lei","year":"2024","unstructured":"Lei, Z. et al. CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis. J. Hepatol. 80 (2), 194\u2013208. https:\/\/doi.org\/10.1016\/j.jhep.2023.10.025 (2024).","journal-title":"J. Hepatol."},{"issue":"6","key":"32711_CR30","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1002\/hep.28820","volume":"64","author":"S Tanaka","year":"2016","unstructured":"Tanaka, S. et al. Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice. Hepatology 64 (6), 1994\u20132014. https:\/\/doi.org\/10.1002\/hep.28820 (2016).","journal-title":"Hepatology"},{"key":"32711_CR31","doi-asserted-by":"publisher","first-page":"101299","DOI":"10.1016\/j.redox.2019.101299","volume":"28","author":"T Zhou","year":"2020","unstructured":"Zhou, T. et al. Mst1 Inhibition attenuates non-alcoholic fatty liver disease via reversing Parkin-related mitophagy. Redox Biol. 28, 101299. https:\/\/doi.org\/10.1016\/j.redox.2019.101299 (2020).","journal-title":"Redox Biol."},{"issue":"1","key":"32711_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13045-025-01726-x","volume":"18","author":"J Tang","year":"2025","unstructured":"Tang, J. et al. Necroptosis in cancer: insight from epigenetic, post-transcriptional and post-translational modifications. J. Hematol. Oncol. 18 (1), 77. https:\/\/doi.org\/10.1186\/s13045-025-01726-x (2025).","journal-title":"J. Hematol. Oncol."},{"key":"32711_CR33","doi-asserted-by":"publisher","first-page":"155516","DOI":"10.1016\/j.metabol.2023.155516","volume":"141","author":"J Park","year":"2023","unstructured":"Park, J. et al. Metformin-induced TTP mediates communication between Kupffer cells and hepatocytes to alleviate hepatic steatosis by regulating lipophagy and necroptosis. Metabolism 141, 155516. https:\/\/doi.org\/10.1016\/j.metabol.2023.155516 (2023).","journal-title":"Metabolism"},{"key":"32711_CR34","doi-asserted-by":"publisher","first-page":"1480027","DOI":"10.3389\/fimmu.2025.1480027","volume":"16","author":"K Yao","year":"2025","unstructured":"Yao, K. et al. RIPK1 in necroptosis and recent progress in related pharmaceutics. Front. Immunol. 16, 1480027. https:\/\/doi.org\/10.3389\/fimmu.2025.1480027 (2025).","journal-title":"Front. Immunol."},{"issue":"6","key":"32711_CR35","doi-asserted-by":"publisher","first-page":"167828","DOI":"10.1016\/j.bbadis.2025.167828","volume":"1871","author":"M Tayir","year":"2025","unstructured":"Tayir, M. et al. The function of necroptosis in liver cancer. Biochim. Biophys. Acta Mol. Basis Dis. 1871 (6), 167828. https:\/\/doi.org\/10.1016\/j.bbadis.2025.167828 (2025).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"6","key":"32711_CR36","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jcmgh.2023.03.002","volume":"15","author":"J Vonderlin","year":"2023","unstructured":"Vonderlin, J. et al. The multifaceted roles of macrophages in NAFLD pathogenesis. Cell. Mol. Gastroenterol. Hepatol. 15 (6), 1311\u20131324. https:\/\/doi.org\/10.1016\/j.jcmgh.2023.03.002 (2023).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"32711_CR37","doi-asserted-by":"publisher","first-page":"1150118","DOI":"10.3389\/fendo.2023.1150118","volume":"14","author":"SJ Park","year":"2023","unstructured":"Park, S. J. et al. Major roles of Kupffer cells and macrophages in NAFLD development. Front. Endocrinol. (Lausanne). 14, 1150118. https:\/\/doi.org\/10.3389\/fendo.2023.1150118 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"32711_CR38","doi-asserted-by":"publisher","first-page":"113808","DOI":"10.1016\/j.intimp.2024.113808","volume":"146","author":"Y Zhao","year":"2025","unstructured":"Zhao, Y. et al. Kupffer cells, the limelight in the liver regeneration. Int. Immunopharmacol. 146, 113808. https:\/\/doi.org\/10.1016\/j.intimp.2024.113808 (2025).","journal-title":"Int. Immunopharmacol."},{"key":"32711_CR39","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.molimm.2017.02.018","volume":"85","author":"P Li","year":"2017","unstructured":"Li, P. et al. The role of Kupffer cells in hepatic diseases. Mol. Immunol. 85, 222\u2013229. https:\/\/doi.org\/10.1016\/j.molimm.2017.02.018 (2017).","journal-title":"Mol. Immunol."},{"issue":"8077","key":"32711_CR40","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41586-025-09190-w","volume":"644","author":"H Huang","year":"2025","unstructured":"Huang, H. et al. Kupffer cell programming by maternal obesity triggers fatty liver disease. Nature 644 (8077), 790\u2013798. https:\/\/doi.org\/10.1038\/s41586-025-09190-w (2025).","journal-title":"Nature"},{"issue":"13","key":"32711_CR41","doi-asserted-by":"publisher","first-page":"e70549","DOI":"10.1111\/jcmm.70549","volume":"29","author":"Y Li","year":"2025","unstructured":"Li, Y. et al. Kupffer cells regulate iNKT cells through Il-12 to mitigate the extent of APAP-Induced damage in the liver. J. Cell. Mol. Med. 29 (13), e70549. https:\/\/doi.org\/10.1111\/jcmm.70549 (2025).","journal-title":"J. Cell. Mol. Med."},{"key":"32711_CR42","doi-asserted-by":"publisher","first-page":"1444198","DOI":"10.3389\/fcell.2024.1444198","volume":"12","author":"Y Tian","year":"2024","unstructured":"Tian, Y. et al. Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy. Front. Cell. Dev. Biol. 12, 1444198. https:\/\/doi.org\/10.3389\/fcell.2024.1444198 (2024).","journal-title":"Front. Cell. Dev. Biol."},{"issue":"764","key":"32711_CR43","doi-asserted-by":"publisher","first-page":"eadi0284","DOI":"10.1126\/scitranslmed.adi0284","volume":"16","author":"I Jeelani","year":"2024","unstructured":"Jeelani, I. et al. HIF-2\u03b1 drives hepatic Kupffer cell death and Proinflammatory recruited macrophage activation in nonalcoholic steatohepatitis. Sci. Transl Med. 16 (764), eadi0284. https:\/\/doi.org\/10.1126\/scitranslmed.adi0284 (2024).","journal-title":"Sci. Transl Med."},{"key":"32711_CR44","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/978-3-031-65944-7_7","volume":"74","author":"P Horn","year":"2024","unstructured":"Horn, P. & Tacke, F. Liver macrophage diversity in health and disease. Results Probl. Cell. Differ. 74, 175\u2013209. https:\/\/doi.org\/10.1007\/978-3-031-65944-7_7 (2024).","journal-title":"Results Probl. Cell. Differ."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32711-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32711-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32711-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:09:02Z","timestamp":1769213342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32711-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["32711"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32711-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7611399\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"14 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article does not contain any studies with human participants (Clinical trial number: not applicable). Besides, animals were housed and operated in strict compliance with the ethical principles of animal experimentation, and the operations were ratified by the animal ethics committee (approval number: 20241110). All animal experiments complied with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals. Besides, all animal experiments as in accordance with the ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"2817"}}